MedTrace Logo

3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women

NCT01409226 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-04-05

No results posted yet for this study

Summary

This study is to find out if 3.0 Tesla (3.0-T) Magnetic Resonance Imaging (MRI) will improve in diagnosing breast cancer in women with high-risk of breast cancer.

Conditions

Interventions

DEVICE

3.0-T MRI

Participants undergo MRI prior to biopsy.

PROCEDURE

biopsy

Participants undergo breast biopsy after 3.0-T MRI.

Sponsors & Collaborators

Principal Investigators

  • Linda Moy, MD · NYU Langone Health

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01409226 on ClinicalTrials.gov